Summary
Michael Nome is a Senior Clinical Scientist with a decade of experience leading Phase 1–4 trials across immunology, IBD, rare disease and celiac disease, currently advancing clinical science at Takeda. He combines protocol development, regulatory strategy, and medical monitoring with strong data-driven process optimization to accelerate enrollment and improve patient safety. Michael has a track record of translating complex regulatory interactions into actionable study materials—co-authoring an FDA briefing book and streamlining ICFs, SOAs, and eCRFs to cut startup timelines. Beyond industry, he co-founded and runs a K–12 school, demonstrating operational leadership, digital transformation, and community impact at scale. His background in pharmacy, radiopharmacy, and radiopharmaceutical research underpins a practical fluency in lab-to-clinic translation and safety-compliant data systems. He also contributes to public health policy and mentorship, blending academic rigor with pragmatic program delivery.
11 years of coding experience
3 years of employment as a software developer
Doctor of Pharmacy - PharmD, Pharmacy, Doctor of Pharmacy - PharmD, Pharmacy at University of Wisconsin-Madison
Bachelor of Science - BS, General Studies, Nuclear Medicine, Bachelor of Science - BS, General Studies, Nuclear Medicine at University of Wisconsin-La Crosse
English, French, creoles and pidgins, english-based, Igbo